Breaking Barriers: Neuroendocrine Cancer UK Launches Ideal Patient Care Pathway Campaign

Neuroendocrine Cancer UK has launched a major campaign to implement a dedicated neuroendocrine cancer pathway into NHS England. This aims to address the persistent challenges and inequities in diagnosis and disease management that have been affecting patients with neuroendocrine cancers, also known as neuroendocrine neoplasms (NENs), in England.

Despite being the 10th most prevalent cancer in England, national cancer plans do not currently represent the neuroendocrine cancer community. Therefore, the development of a patient care pathway for neuroendocrine cancer is critical in supporting optimal care provision for all those diagnosed within existing expert multidisciplinary teams.

Working in close collaboration with a multidisciplinary advisory group, the ideal patient care pathway has been designed to align with NHS England’s Long-Term Plan goals. Its effective integration within NHS England is a key priority to achieving optimal care provision for all people with neuroendocrine cancers.

“We firmly believe that every patient deserves access to the best possible care, and we are committed to doing everything in our power to make this a reality,” said Neuroendocrine Cancer UK in a statement.

The campaign aims to spread awareness of the issues facing the neuroendocrine cancer community and advocate for their inclusion in national cancer plans. By sharing the campaign video and commenting on the challenges faced, we can work towards ensuring that everyone living with neuroendocrine cancer receives the right care, in the right place, at the right time.

Join the campaign and show your support for the optimal care provision for all people with neuroendocrine cancer. Share the video and use the hashtags #Nccarepathway to spread awareness and make some noise.  Visit the website here…